Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Immune checkpoint inhibitors (ICIs) show limited efficacy in hepatocellular carcinoma (HCC) owing to an immunosuppressive tumor microenvironment (TME). Although ubiquitin-specific peptidase 39 (USP39) promotes tumor progression, its role in mediating ICI resistance remains unclear. This study aimed to elucidate how USP39 drives immunosuppression and assess its therapeutic potential in HCC.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.